Aktie A246960 SCL SCIENCE INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen SCL Science Inc.

Aktien

A246960

KR7246960009

A246960

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
9.760 KRW -1,01 % Intraday Chart für SCL Science Inc. -4,41 % +10,03 %
2023 Lee Moon Su hat den Erwerb einer 98,04%igen Beteiligung an NVC 2019 Bio Health Care Investment Association von InnoTherapy, Inc. (KOSDAQ:A246960) abgeschlossen CI
2022 SCL Healthcare Co., Ltd. hat die Übernahme von 22,97% der Anteile an InnoTherapy, Inc. (KOSDAQ:A246960) von Lee, Moon Soo, abgeschlossen. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc.
H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 5.9999961 billion in funding from Scl Holdings and another investor
Health to U Corporation announced that it has received funding from InnoTherapy, Inc.
H2U Corp. announced that it expects to receive KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it expects to receive KRW 5.9999961 billion in funding
PhAST Corp. announced that it has received KRW 1.30609774 billion in funding from InnoTherapy, Inc.
Lee Moon Su completed the acquisition of a 98.04% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc.
Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. for approximately KRW5 billion.
PhAST Corp. announced that it expects to receive KRW 1.30609774 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
InnoTherapy, Inc. announced that it expects to receive KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
SCL Healthcare Co., Ltd. completed the acquisition of 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo.
SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.
InnoTherapy, Inc. announced that it has received KRW 14.999868397 billion in funding from a group of investors
InnoTherapy, Inc. announced that it expects to receive KRW 7.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, His-Story Investment Co.,Ltd., Shinhan Bank, Investment Arm, Shinhan Bank, Investment Arm, and Pureun Mutual Savings Bank Co., Ltd and another investor
InnoTherapy, Inc. cancelled the acquisition of 98.04% stake in NVC 2019 Bio Health Care Investment Association.
InnoTherapy, Inc. agreed to acquire 98.04% stake in NVC 2019 Bio Health Care Investment Association for KRW 5 billion.
NVC Partners announced that it has received KRW 1.1 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. has completed an IPO in the amount of KRW 9 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A246960 Aktie
  4. Nachrichten SCL Science Inc.
  5. Andere Sprachen